← Dashboard
Stock
CNC
CENTENE CORPORATIONHealth CareManaged Health CareLatest close $589 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
9
27 funds tracked
Ever held
15
Current + past
New this quarter
1
Exited this quarter
0
Marquee-fund ownership over time
Aug 14, 2014Aug 13, 2019Aug 14, 2024May 15, 2026
Now
9
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Glenview Capital re-entered | Q4 2014 | 47Q | $24 | $58 | +141% |
| Bridgewater Associates re-entered | Q3 2021 | 20Q | $63 | $58 | -8% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $77 | $58 | -24% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $77 | $58 | -24% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $77 | $58 | -24% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $77 | $58 | -24% |
| Renaissance Technologies re-entered | Q4 2024(8Q snapshot) | 6Q | $58 | $58 | +0% |
| Two Sigma Investments | Q4 2024(8Q snapshot) | 6Q | $59 | $58 | -1% |
| Point72 Asset Management re-entered | Q4 2024(8Q snapshot) | 6Q | $59 | $58 | -1% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Maverick Capital 5× in & out | Q3 2023 | Q2 2025 | → $60 | -10% |
| Viking Global Investors 3× in & out | Q3 2018 | Q4 2022 | → $82 | +14% |
| Third Point | Q3 2019 | Q3 2020 | → $64 | +29% |
| Greenlight Capital | Q2 2020 | Q3 2020 | → $65 | -6% |
| Appaloosa 2× in & out | Q3 2019 | Q4 2019 | → $55 | +14% |
| JANA Partners | Q1 2019 | Q2 2019 | → $54 | -15% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at CENTENE CORP. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
10
Filings · last 90d
21
Total on file
622
Recent SEC buffer
Most recent
Jun 2, 2026
30d / 90d windows measured from Jun 2, 2026 — the most recent Form 4 on file — not from today.
- Form 40001071739-26-000125Jun 2, 2026
- Form 40001071739-26-000123May 26, 2026
- Form 40001071739-26-000115May 13, 2026
- Form 40001071739-26-000114May 13, 2026
- Form 40001071739-26-000113May 13, 2026
- Form 40001071739-26-000112May 13, 2026
- Form 40001071739-26-000111May 13, 2026
- Form 40001071739-26-000110May 13, 2026
- Form 40001071739-26-000109May 13, 2026
- Form 40001071739-26-000108May 13, 2026
- Form 40001071739-26-000091Apr 16, 2026
- Form 40001071739-26-000089Mar 31, 2026
- Form 40001071739-26-000088Mar 31, 2026
- Form 40001071739-26-000087Mar 31, 2026
- Form 40001071739-26-000086Mar 31, 2026
Showing 15 of 622 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · CENTENE CORPORATIONAnnual figures sourced directly from CENTENE CORPORATION's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$194.78B
FY2025+19% YoY
Net income
-$6.67B
FY2025-302% YoY
EPS (diluted)
$-13.53
FY2025-314% YoY
Free cash flow(?)
$4.32B
FY2025+500%+ YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for CENTENE CORP — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 15, 2026
- 8-KMaterial eventApr 28, 2026
- 10-QQuarterly reportApr 28, 2026
- DEF 14AProxy statementMar 26, 2026
- 8-KMaterial eventMar 24, 2026
- 8-KMaterial eventMar 10, 2026
- 8-KMaterial eventFeb 23, 2026
- 10-KAnnual reportFeb 17, 2026
- 8-KMaterial eventFeb 6, 2026
- 8-KMaterial eventNov 10, 2025
- 8-KMaterial eventOct 29, 2025
- 10-QQuarterly reportOct 29, 2025
- 8-KMaterial eventSep 11, 2025
- 8-KMaterial eventAug 15, 2025
- 8-KMaterial eventAug 4, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Point72 Asset Management | Q2 2026 | open | $58 | $58 | -0% |
| Renaissance Technologies | Q1 2026 | open | $39 | $58 | +49% |
| Glenview Capital | Q4 2025 | open | $36 | $58 | +60% |
| Point72 Asset Management | Q4 2025 | Q1 2026 | $36 | $41 | +13% |
| Renaissance Technologies | Q3 2025 | Q4 2025 | $27 | $36 | +33% |
| Glenview Capital | Q1 2025 | Q3 2025 | $57 | $27 | -53% |
| Two Sigma Investments | Q4 2024 | open | $59 | $58 | -1% |
| Point72 Asset Management | Q4 2024 | Q2 2025 | $59 | $60 | +2% |
| Renaissance Technologies | Q4 2024 | Q1 2025 | $58 | $57 | -2% |
| Citadel Advisors | Q3 2024 | open | $77 | $58 | -24% |
| Glenview Capital | Q3 2024 | Q4 2024 | $77 | $59 | -24% |
| D.E. Shaw | Q3 2024 | open | $77 | $58 | -24% |
| AQR Capital Management | Q3 2024 | open | $77 | $58 | -24% |
| Millennium Management | Q3 2024 | open | $77 | $58 | -24% |
| Maverick Capital | Q3 2023 | Q2 2025 | $67 | $60 | -10% |
| Bridgewater Associates | Q2 2022 | open | $82 | $60 | -27% |
| Glenview Capital | Q3 2021 | Q4 2022 | $64 | $82 | +28% |
| Maverick Capital | Q3 2021 | Q1 2022 | $64 | $82 | +28% |
| Bridgewater Associates | Q3 2021 | Q1 2022 | $63 | $82 | +30% |
| Greenlight Capital | Q2 2020 | Q3 2020 | $69 | $65 | -6% |
| Appaloosa | Q3 2019 | Q4 2019 | $48 | $55 | +14% |
| Third Point | Q3 2019 | Q3 2020 | $50 | $64 | +29% |
| Glenview Capital | Q2 2019 | Q3 2020 | $54 | $65 | +19% |
| JANA Partners | Q1 2019 | Q2 2019 | $64 | $54 | -15% |
| Viking Global Investors | Q3 2018 | Q4 2022 | $72 | $82 | +14% |
| Maverick Capital | Q2 2018 | Q2 2021 | $57 | $71 | +25% |
| Appaloosa | Q1 2017 | Q1 2019 | $35 | $64 | +80% |
| Maverick Capital | Q1 2017 | Q2 2017 | $35 | $38 | +8% |
| Viking Global Investors | Q3 2016 | Q3 2017 | $35 | $41 | +17% |
| Maverick Capital | Q2 2016 | Q3 2016 | $29 | $35 | +24% |
| Glenview Capital | Q4 2014 | Q1 2015 | $24 | $30 | +24% |
| Viking Global Investors | Q3 2014 | Q4 2014 | $19 | $24 | +30% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.